{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:42:35Z","timestamp":1784284955970,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04301-1","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:47:18Z","timestamp":1751636838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of clinical pharmacy services on medication adherence and quality of life in pre-dialysis patients with CKDu: a randomized controlled trial from Sri Lanka"],"prefix":"10.1186","volume":"26","author":[{"given":"Dilmi","family":"Wickramasinghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaluka","family":"Jayamanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamila De","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"4301_CR1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA - J Am Med Association. 2019;322:1294\u2013304.","journal-title":"JAMA - J Am Med Association"},{"key":"4301_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S2213-8587(17)30310-8","volume":"6","author":"A Covic","year":"2018","unstructured":"Covic A, Vervloet M, Massy ZA, et al. Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. Lancet Diabetes Endocrinol. 2018;6:319\u201331.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4301_CR3","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","volume":"119","author":"C Zoccali","year":"2023","unstructured":"Zoccali C, Mallamaci F, Adamczak M, et al. Cardiovascular complications in chronic kidney disease: a review from the European renal and cardiovascular medicine working group of the European renal association. Cardiovasc Res. 2023;119:2017\u201332.","journal-title":"Cardiovasc Res"},{"key":"4301_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1590\/S1807-59322011000600012","volume":"66","author":"MC Cruz","year":"2011","unstructured":"Cruz MC, Andrade C, Urrutia M, Draibe S, Nogueira-Martins LA, de Sesso R CC. Quality of life in patients with chronic kidney disease. Clinics. 2011;66:991\u20135.","journal-title":"Clinics"},{"key":"4301_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/10773525.2016.1203097","volume":"22","author":"S Rajapakse","year":"2016","unstructured":"Rajapakse S, Shivanthan MC, Selvarajah M. Chronic kidney disease of unknown etiology in Sri Lanka. Int J Occup Environ Health. 2016;22:259\u201364.","journal-title":"Int J Occup Environ Health"},{"key":"4301_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ekir.2019.03.020","volume":"4","author":"ES Wijewickrama","year":"2019","unstructured":"Wijewickrama ES, Gunawardena N, Jayasinghe S, Herath C. CKD of unknown etiology (CKDu) in Sri lanka: A multilevel clinical case definition for surveillance and epidemiological studies. Kidney Int Rep. 2019;4:781\u20135.","journal-title":"Kidney Int Rep"},{"key":"4301_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-015-0052-2","author":"D Cooney","year":"2015","unstructured":"Cooney D, Moon H, Liu Y, Miller RT, Perzynski A, Watts B, Drawz PE. A pharmacist based intervention to improve the care of patients with CKD: A pragmatic, randomized, controlled trial. BMC Nephrol. 2015. https:\/\/doi.org\/10.1186\/s12882-015-0052-2.","journal-title":"BMC Nephrol"},{"key":"4301_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-023-03210-5","author":"A Pehlivanli","year":"2023","unstructured":"Pehlivanli A, Eyupoglu S, Basgut B, Erturk S, Ozcelikay AT. Impact of a multidisciplinary approach involving clinical pharmacist on resolving drug related problems in chronic kidney patients: a prospective interventional study. BMC Nephrol. 2023. https:\/\/doi.org\/10.1186\/s12882-023-03210-5.","journal-title":"BMC Nephrol"},{"key":"4301_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/PPA.S436952","volume":"18","author":"T Wang","year":"2024","unstructured":"Wang T, Kang HC, Chen CC, Lai TS, Huang CF, Wu CC. The effects of Pharmacist-Led medication therapy management on medication adherence and use of Non-Steroidal Anti-Inflammatory drug in patients with Pre-End stage renal disease. Patient Prefer Adherence. 2024;18:267\u201374.","journal-title":"Patient Prefer Adherence"},{"key":"4301_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.22270\/jddt.v10i3-s.4083","volume":"10","author":"CS Varghese","year":"2020","unstructured":"Varghese CS, Naik HK, Sangeetha R, Srinivasan R. A study on medication adherence and quality of life in patients with chronic kidney disease. J Drug Delivery Ther. 2020;10:52\u201360.","journal-title":"J Drug Delivery Ther"},{"key":"4301_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ndt\/gfr287","volume":"27","author":"TM Salgado","year":"2012","unstructured":"Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Pharmacists\u2019 interventions in the management of patients with chronic kidney disease: A systematic review. Nephrol Dialysis Transplantation. 2012;27:276\u201392.","journal-title":"Nephrol Dialysis Transplantation"},{"key":"4301_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/ckj\/sfz046","volume":"12","author":"IM Schmidt","year":"2019","unstructured":"Schmidt IM, H\u00fcbner S, Nadal J, et al. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German chronic kidney disease study. Clin Kidney J. 2019;12:663\u201372.","journal-title":"Clin Kidney J"},{"key":"4301_CR13","first-page":"2023","volume":"26","author":"RN Okoro","year":"2023","unstructured":"Okoro RN, Ummate I, David Ohieku J, Yakubu SI, Adibe MO. Effectiveness of pharmacist intervention in improving medication adherence in patients with chronic kidney disease: a randomised controlled trial in Nigeria. Afr J Nephrol Official Publication Afr Association Nephrol. 2023;26:2023.","journal-title":"Afr J Nephrol Official Publication Afr Association Nephrol"},{"key":"4301_CR14","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2023.3.2859","author":"GS Paneerselvam","year":"2023","unstructured":"Paneerselvam GS, Kenneth LKC, Aftab RA, Sirisinghe RG. Medication adherence among Hemodialysis patients: the impact of pharmacist-led motivational interviewing. Pharm Pract (Granada). 2023. https:\/\/doi.org\/10.18549\/PharmPract.2023.3.2859.","journal-title":"Pharm Pract (Granada)"},{"key":"4301_CR15","doi-asserted-by":"crossref","unstructured":"Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol 12. 2011.","DOI":"10.1186\/1471-2369-12-35"},{"key":"4301_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/j.akdh.2023.08.003","volume":"31","author":"W Tesfaye","year":"2024","unstructured":"Tesfaye W, Parrish N, Sud K, Grandinetti A, Castelino R. Medication adherence among patients with kidney disease: an umbrella review. Adv Kidney Disease Health. 2024;31:68\u201383.","journal-title":"Adv Kidney Disease Health"},{"key":"4301_CR17","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/heapol\/czy081","volume":"33","author":"R Dodd","year":"2018","unstructured":"Dodd R, Palagyi A, Guild L, Jha V, Jan S. The impact of out-of-pocket costs on treatment commencement and adherence in chronic kidney disease: A systematic review. Health Policy Plan. 2018;33:1047\u201354.","journal-title":"Health Policy Plan"},{"key":"4301_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-019-0522-6","author":"R Kumar","year":"2019","unstructured":"Kumar R. Public-private partnerships for universal health coverage? The future of free health in Sri Lanka. Global Health. 2019. https:\/\/doi.org\/10.1186\/s12992-019-0522-6.","journal-title":"Global Health"},{"key":"4301_CR19","unstructured":"Mamunuwa A, Dorabawila S. The need for clinical pharmacy services in Sri Lanka; a study based on the prevalence of drug related problems in two hospitals. Int J Sci Res Publications 4. 2014."},{"key":"4301_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2471\/BLT.17.198366","volume":"96","author":"LGT Shanika","year":"2018","unstructured":"Shanika LGT, Jayamanne S, Wijekoon CN, Coombes J, Perera D, Mohamed F, Coombes I, De Silva HA, Dawson AH. Ward-based clinical pharmacists and hospital readmission: A non-randomized controlled trial in Sri Lanka. Bull World Health Organ. 2018;96:155\u201364.","journal-title":"Bull World Health Organ"},{"key":"4301_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2001-1","author":"LGT Shanika","year":"2017","unstructured":"Shanika LGT, Wijekoon CN, Jayamanne S, Coombes J, Coombes I, Mamunuwa N, Dawson AH, De Silva HA. Acceptance and attitudes of healthcare staff towards the introduction of clinical pharmacy service: A descriptive cross-sectional study from a tertiary care hospital in Sri Lanka. BMC Health Serv Res. 2017. https:\/\/doi.org\/10.1186\/s12913-017-2001-1.","journal-title":"BMC Health Serv Res"},{"key":"4301_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/ajprhc.ajprhc_36_24","volume":"16","author":"D Wickramasinghe","year":"2024","unstructured":"Wickramasinghe D, Lynch C, Coombes J, Jayamanne S, De Silva S. Improving Drug- and Disease-related knowledge of patients with chronic kidney disease: randomized controlled trial from a Sri Lankan outpatient clinic. Asian J Pharm Res Health Care. 2024;16:208\u201315.","journal-title":"Asian J Pharm Res Health Care"},{"key":"4301_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11255-020-02452-8","volume":"52","author":"JJB Seng","year":"2020","unstructured":"Seng JJB, Tan JY, Yeam CT, Htay H, Foo WYM. Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature. Int Urol Nephrol. 2020;52:903\u201316.","journal-title":"Int Urol Nephrol"},{"key":"4301_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-180","author":"N Jayatilake","year":"2013","unstructured":"Jayatilake N, Mendis S, Maheepala P, Mehta FR. Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country. BMC Nephrol. 2013. https:\/\/doi.org\/10.1186\/1471-2369-14-180.","journal-title":"BMC Nephrol"},{"key":"4301_CR25","unstructured":"Initial environmental examination Sri Lanka: health system enhancement project sub-projects proposed for round 2, phase II in the Anuradhapura District. 2021."},{"key":"4301_CR26","unstructured":"Dassanayake R, Herath N. Screening guidelines. Chronic kidney Disease, Sri Lanka. 2017."},{"key":"4301_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0738-3991(98)00107-4","volume":"37","author":"BL Svarstad","year":"1999","unstructured":"Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113\u201324.","journal-title":"Patient Educ Couns"},{"key":"4301_CR28","unstructured":"Hays RD, Kallich JD, Mapes DL, Coons SJ, Naseem A, Carter WB, Kamberg C. Kidney disease quality of life short forma (KDQOL-SFtm), version 1.3. A Manuel for Usea and Scoring. 1997;1\u201343."},{"key":"4301_CR29","doi-asserted-by":"crossref","unstructured":"Saban KL, Bryant FB, Reda DJ, Stroupe KT, Hynes DM. Measurement invariance of the kidney disease and quality of life instrument (KDQOL-SF) across veterans and non-Veterans. 2010.","DOI":"10.1186\/1477-7525-8-120"},{"key":"4301_CR30","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2215\/CJN.05541008","volume":"4","author":"SK Mujais","year":"2009","unstructured":"Mujais SK, Story K, Brouillette J, Takano T, Soroka S, Franek C, Mendelssohn D, Finkelstein FO. Health-related quality of life in CKD patients: correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4:1293\u2013301.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4301_CR31","first-page":"656","volume":"6","author":"L Wei","year":"2014","unstructured":"Wei L, Yang X, Li J, Liu L, Luo H, Zheng Z, Wei Y. Effect of pharmaceutical care on medication adherence and hospital admission in patients with chronic obstructive pulmonary disease (COPD): A randomized controlled study. J Thorac Dis. 2014;6:656\u201362.","journal-title":"J Thorac Dis"},{"key":"4301_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/jamainternmed.2013.12944","volume":"174","author":"PM Ho","year":"2014","unstructured":"Ho PM, Lambert-Kerzner A, Carey EP, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: A randomized clinical trial. JAMA Intern Med. 2014;174:186\u201393.","journal-title":"JAMA Intern Med"},{"key":"4301_CR33","unstructured":"Sealed Envelope Ltd. Simple randomisation service. 2022. [online]. In: https:\/\/www.sealedenvelope.com\/simple-randomiser\/v1\/"},{"key":"4301_CR34","doi-asserted-by":"crossref","unstructured":"Ware JE. The MOS 36-item short-form health survey (SF-36). Med Care 30. 1992.","DOI":"10.1097\/00005650-199206000-00002"},{"key":"4301_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5530\/jyp.2018.10.46","volume":"10","author":"D Chandrasekhar","year":"2018","unstructured":"Chandrasekhar D, Ganesan VM, Sreekumar S, Pradeep A, Geoji AS, George AE, Athira V. Impact of intensified pharmaceutical interventions in medication adherence in chronic kidney disease patients. J Young Pharmacists. 2018;10:208\u201312.","journal-title":"J Young Pharmacists"},{"key":"4301_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14740\/wjnu188w","volume":"3","author":"J Shareef","year":"2014","unstructured":"Shareef J, S KG, Baikunje S. Impact of pharmacists\u2019 counseling on quality of life in patients undergoing Hemodialysis in a tertiary care teaching hospital. World J Nephrol Urol. 2014;3:143\u201350.","journal-title":"World J Nephrol Urol"},{"key":"4301_CR37","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/j.sapharm.2021.02.010","volume":"17","author":"A Al-mansouri","year":"2021","unstructured":"Al-mansouri A, Al-Ali FS, Hamad AI, Mohamed Ibrahim MI, Kheir N, Ibrahim RA, AlBakri M, Awaisu A. Assessment of treatment burden and its impact on quality of life in dialysis-dependent and pre-dialysis chronic kidney disease patients. Res Social Administrative Pharm. 2021;17:1937\u201344.","journal-title":"Res Social Administrative Pharm"},{"key":"4301_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/0975-1483.96623","volume":"4","author":"KV Ramanath","year":"2012","unstructured":"Ramanath KV, Balaji DBSS, Nagakishore CH, Mahesh Kumar S, Bhanuprakash M. A study on impact of clinical pharmacist interventions on medication adherence and quality of life in rural hypertensive patients. J Young Pharmacists. 2012;4:95\u2013100.","journal-title":"J Young Pharmacists"},{"key":"4301_CR39","unstructured":"James M, Roy A, Antony E, George S. Impact of patient counseling on treatment adherence behavior and quality of life in maintenance Hemodialysis patients. Saudi Journal of Kidney Disease and Transplantation. 2021."},{"key":"4301_CR40","unstructured":"(2023) Kidney disease: a UK public health emergency. The health economics of kidney disease to 2033."},{"key":"4301_CR41","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117\u2013314.","journal-title":"Kidney Int"},{"key":"4301_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell C, Levey AS, et al. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395:709\u201333.","journal-title":"Lancet"},{"key":"4301_CR43","unstructured":"World health organization RO for S-E Asia. Introduction to the sustainable development goals (SDGs). 2017."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04301-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04301-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04301-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:47:22Z","timestamp":1751636842000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04301-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4301"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04301-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. The study was approved by the Ethics Review Committee, Faculty of Medicine, University of Kelaniya, Sri Lanka (P\/148\/09\/2015) and it is in compliance with the Helsinki declaration. All study participants signed written informed consent prior to study enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"351"}}